VERAPAMIL HYDROCHLORIDE
- Product NDC
- 71610-377
- 11-digit product format
- 716100377
- Labeler code
- 71610
- Product ID
- 71610-377_5ef72e68-dce5-4845-8a3d-fde812af049f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- VERAPAMIL HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA206173
- Marketing category
- ANDA
- Marketing start
- 2019-05-15
- Marketing end
- 0000-00-00
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 240 mg/1
- Pharmacologic classes
- P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71610-377-60 | VERAPAMIL HYDROCHLORIDE | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-377 | VERAPAMIL HYDROCHLORIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC, 1 package rows | 20200125_4f2ef5e8-a11f-4123-af41-95f4ed7377d6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-377-60 | 71610037760 | 90 TABLET in 1 BOTTLE (71610-377-60) | 90 tablet | 2019-12-26 | 0000-00-00 | No | No | Current |